COVID-19 Vaccination Intent and Perceptions Among Patients With Inflammatory Bowel Diseases

Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved..

Patients with inflammatory bowel disease (IBD) develop coronavirus disease 2019 (COVID-19) at similar rates as the general population, and there was initial concern regarding potential for severe illness.1-4 Vaccinations were authorized for emergency use in the United States in December 2020 and aim to halt the spread of COVID-19. However, there are concerns that people will be hesitant to receive the vaccine for a variety of reasons including insufficient data in certain populations including those with IBD. We surveyed patients with IBD to identify potential concerns regarding COVID-19 vaccination.

Media Type:

Electronic Article

Year of Publication:

2021

Contained In:

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association - Vol. 19, No. 8 (2021), p. 1730-1732.e2

Language:

English

Contributors:

Dalal, Rahul S
McClure, Emma
Marcus, Jenna
Winter, Rachel W
Hamilton, Matthew J
Allegretti, Jessica R

Links:

Volltext

Keywords:

Journal Article

Notes:

Date Revised 22.07.2021

published: Print-Electronic

Citation Status In-Process

Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Physical Description:

Online-Ressource

doi:

10.1016/j.cgh.2021.02.004

PMID:

33549869

PPN (Catalogue-ID):

NLM322151449